Federal investigators late last month moved to drop charges against 1 of the quartet of suspects accused of insider trading in connection with Abbott‘s (NYSE:ABT) $2.8 billion buyout of Advanced Medical Optics in 2009.
Insider Trading
Stryker exec charged in $1.7M insider trading scheme | MassDevice.com On Call
Edwards Lifesciences insiders keep selling | Wall Street Beat
Edwards Lifesciences (NYSE:EW) insiders aren’t buying, and they haven’t been for several months, according to a report.
Although insiders have been selling shares, 3 of them in the last week, none have purchased any since at least April, SeekingAlpha reported.
SEC indicts baseball great Eddie Murray, Abbott exec
Report: Feds investigating Hall of Famer Murray, Abbott exec in insider trading probe
Federal investigators are looking into possible insider trading in Abbott’s 2009 buyout of Advanced Medical Optics for $2.8 billion by baseball players including Hall of Fame slugger Eddie Murray and former AMO head James Mazzo.
Citing "people familiar with the 3-year-old probe," the Reuters news service said securities regulators and prosecutors are investigating whether Murray acted on advance notice of the deal. Murray has not been charged.
VLV sues Becton, Dickinson over ‘bloodless catheter’ patent | Legal News
Becton Dickinson & Co. (NYSE:BDX) is facing a patent infringement lawsuit filed by VLV Assoc., a small medical device company based in New Jersey, accusing it of infringing VLV’s patent for a "bloodless catheter."
MassDevice.com +7 | MDT to cut $1.2B, Acquisition chatter for SNN, Olympus’s fire sale, FDA chemist, Bovie’s COO, FDA’s artificial pancreas guidance and St. Judes’ Quantra win
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
FDA chemist to pay back $4M but admits no guilt in SEC settlement
A former FDA chemist who faces 20 years in prison after pleading guilty to using a confidential agency database to time stock market trades agreed to pay back the $3.8 million he made with the illicit trades.
Cheng Yi Liang admitted last month to using a database of new pharmaceutical applications to suss out drugs that were about to be approved. He would then buy shares in the company that makes the drug just ahead of the approval announcement and sell his stake after share prices jumped on the news.
Medtronic, hacking, stocks, drug-eluting stents, antitrust charges, whistleblowers and insider trading made headlines this week. | MassDevice.com +7
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with Massdevice +7.
Ronda Stryker sets up new stock-selling plan
Ronda Stryker is pruning one of the family trusts again, letting go of approximately 12 percent of its contents and setting up a payday somewhere close to $120 million — by far, her most profitable year yet selling Stryker Corp. (NYSE:SYK) stock.
Feds charge ex-Home Diagnostics CEO with insider trading
The former chairman, president and CEO of Home Diagnostics Inc. is facing insider trading charges from federal prosecutors and the Securities &Exchange Commission, accusing him of tipping off friends and family to Nipro Corp.’s (TYO:8086) $215 million acquisition of the diabetes monitoring equipment maker last year.